The stock price of Mira Pharmaceuticals Inc (NASDAQ: MIRA) has plunged by -3.81 when compared to previous closing price of 1.05, but the company has seen a -9.82% decline in its stock price over the last five trading sessions. accesswire.com reported 2024-12-19 that MIAMI, FL / ACCESSWIRE / December 19, 2024 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a preclinical-stage pharmaceutical company focused on developing therapies for neurological and neuropsychiatric disorders, today announced that it has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for Ketamir-2, its novel oral ketamine analog for the treatment of neuropathic pain. The IND submission marks a major step in advancing Mira’s lead drug candidate while reflecting its commitment to meeting milestones and timelines.
Is It Worth Investing in Mira Pharmaceuticals Inc (NASDAQ: MIRA) Right Now?
The stock has a 36-month beta value of 2.29. Opinions on the stock are mixed, with 2 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for MIRA is 11.05M, and at present, short sellers hold a 6.08% of that float. On December 19, 2024, the average trading volume of MIRA was 1.43M shares.
MIRA’s Market Performance
MIRA stock saw a decrease of -9.82% in the past week, with a monthly decline of -27.86% and a quarterly a decrease of -9.82%. The volatility ratio for the week is 6.44%, and the volatility levels for the last 30 days are 9.76% for Mira Pharmaceuticals Inc (MIRA). The simple moving average for the last 20 days is -16.80% for MIRA stock, with a simple moving average of -18.94% for the last 200 days.
MIRA Trading at -25.41% from the 50-Day Moving Average
After a stumble in the market that brought MIRA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -79.84% of loss for the given period.
Volatility was left at 9.76%, however, over the last 30 days, the volatility rate increased by 6.44%, as shares sank -20.98% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -8.29% lower at present.
During the last 5 trading sessions, MIRA fell by -10.75%, which changed the moving average for the period of 200-days by +4.67% in comparison to the 20-day moving average, which settled at $1.2135. In addition, Mira Pharmaceuticals Inc saw -3.81% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MIRA starting from Aminov Erez, who sale 55,410 shares at the price of $1.39 back on Nov 19 ’24. After this action, Aminov Erez now owns 1,105,790 shares of Mira Pharmaceuticals Inc, valued at $77,020 using the latest closing price.
Aminov Erez, the Chief Executive Officer of Mira Pharmaceuticals Inc, sale 44,590 shares at $1.27 during a trade that took place back on Nov 20 ’24, which means that Aminov Erez is holding 1,061,200 shares at $56,629 based on the most recent closing price.
Stock Fundamentals for MIRA
The total capital return value is set at -3.0. Equity return is now at value -192.32, with -169.22 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 6.11.
Conclusion
To sum up, Mira Pharmaceuticals Inc (MIRA) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
